Comparison of Two Real-Time PCR Assays for Apolipoprotein E Genotyping.
10.15263/jlmqa.2014.36.3.157
- Author:
Yu Jung JUNG
1
;
Rihwa CHOI
;
Jae Young CHUNG
;
Myoung Keun LEE
;
Chang Seok KI
;
Jong Won KIM
Author Information
1. Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. changski@skku.edu
- Publication Type:Brief Communication
- Keywords:
Apolipoprotein E;
Genotype;
Real-time polymerase chain reaction
- MeSH:
Alzheimer Disease;
Apolipoproteins E;
Apolipoproteins*;
Biomarkers;
Cardiovascular Diseases;
Codon;
Dyslipidemias;
Genotype;
Humans;
Real-Time Polymerase Chain Reaction*
- From:Journal of Laboratory Medicine and Quality Assurance
2014;36(3):157-160
- CountryRepublic of Korea
- Language:English
-
Abstract:
Apolipoprotein E (APOE) polymorphisms are used as biological markers to assess the risk of cardiovascular disease, dyslipidemia, and Alzheimer's disease. Consequently, APOE genotyping is one of the most frequently conducted tests in clinical molecular laboratories. Although APOE genotyping may appear to be uncomplicated and a relatively easy test to perform, genotyping errors can still occur due to polymorphisms near codons 112 and 158 in the human APOE gene. Therefore, validation and verification of APOE genotyping assays before clinical use are essential. So far, we have been using the TaqMan SNP Genotyping Assay (Life Technologies, USA). However, recently, the Real-Q ApoE genotyping kit (BioSewoom, Korea) was approved by the Korean Ministry of Food and Drug Safety, which led us to compare the results obtained from this genotyping kit to those of the TaqMan SNP Genotyping Assay. The Real-Q ApoE genotyping kit yielded correct genotyping results for all six APOE genotypes and provided concordant results with the TaqMan SNP Genotyping Assay in a series of blinded comparison samples. Thus, we validated its use in clinical tests.
